Table 3.

Disorders with Features of Poikiloderma in the Differential Diagnosis of Kindler Syndrome

Gene(s)DisorderMOIClinical Characteristics
Ectodermal FindingsOther Findings
ACD
CTC1
DKC1
NHP2
NOP10
PARN
RTEL1
TERC
TERT
TINF2
WRAP53
Dyskeratosis congenita XL
AD
AR
Dysplastic nails, lacy reticular pigmentation of upper chest &/or neck. Poikiloderma & nail dystrophy occur in late childhood.Oral leukoplakia. ↑ risk for progressive bone marrow failure, myelodysplastic syndrome or acute myelogenous leukemia, solid tumors, & pulmonary fibrosis.
ANAPC1
RECQL4
Rothmund-Thomson syndrome ARRash that typically develops ages 3-6 mos (occasionally as late as age 2 yrs) as erythema, swelling, & blistering on face, then spreading to buttocks & extremities. Over mos to yrs, rash evolves into poikiloderma. Sparse hair, eyelashes, &/or eyebrows.Small size; skeletal & dental abnormalities; juvenile cataracts; ↑ risk for cancer, esp osteosarcoma
BLM Bloom syndrome ARSkin at birth & during early infancy appears normal. During 1st or 2nd yr of life, typically following sun exposure, red, sun-sensitive rash appears on nose & cheeks (sometimes also on dorsa of hands & forearms). Rash varies in severity & extent & is usually characterized by telangiectasia but in others is described as poikiloderma.Severe pre- & postnatal growth deficiency, highly characteristic sparseness of subcutaneous fat tissue throughout infancy & early childhood, & short stature throughout postnatal life. Gastroesophageal reflux is common.
CD151 KS-like epidermolysis bullosa 1ARFacial freckling, poikiloderma, atrophy of skin, & acrogeria of backs of hands on sun-exposed areas. Unlike KS, which presents w/blistering during childhood, 1 person described 1 presented widespread blistering & erosions primarily in pretibial area in adulthood. Dystrophic nails in all fingers & toes & early-onset alopecia were also observed.The person described 1 had history of nephropathy manifesting w/proteinuria.
DDB2
ERCC1
ERCC2
ERCC3
ERCC4
ERCC5
POLH
XPA
XPC
Xeroderma pigmentosum (XP)ARSun sensitivity w/marked freckle-like pigmentation of face before age 2 yrs. Sunlight-induced ocular involvement. Greatly ↑ risk of sunlight-induced cutaneous neoplasms. XP typically does not have acral bullae whereas in KS acral bullae are observed in childhood.~25% of affected persons have neurologic manifestations.
FAM111B Hereditary fibrosing poikiloderma w/tendon contractures, myopathy, & pulmonary fibrosis ADPoikiloderma (typically beginning in 1st 6 mos & mainly localized to face), hypohidrosis w/heat intolerance, mild lymphedema of extremities, chronic erythematous & scaly skin lesions on extremities, sclerosis of digits, & mild palmoplantar keratoderma. Typically scalp hair, eyelashes, &/or eyebrows are sparse; nail dysplasia may be assoc.Muscle contractures usually seen in childhood; progressive weakness of proximal & distal muscles of all 4 limbs
USB1 Poikiloderma w/neutropenia (Clericuzio-type poikiloderma w/neutropenia) 2ARInflammatory eczematous rash (ages 6-12 mos) followed by post-inflammatory poikiloderma (age >2 yrs); nail dystrophy & palmar/plantar hyperkeratosisChronic noncyclic neutropenia typically assoc w/recurrent sinopulmonary infections in 1st 2 yrs of life & (often) bronchiectasis. ↑ risk for myelodysplastic syndrome. Reactive airway disease.

From: Kindler Syndrome

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.